EC

Elmind Capital Portfolio holdings

AUM $352M
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
–
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$352M
AUM Growth
+$13.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
36
New
Increased
Reduced
Closed

Top Buys

1
+$19.5M
2
+$5.54M
3
+$3.55M
4
ALMS
Alumis Inc
ALMS
+$3.25M
5
CGEM icon
Cullinan Oncology
CGEM
+$2.83M

Top Sells

1
+$11.4M
2
+$10.5M
3
+$9.61M
4
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$8.93M
5
WVE icon
Wave Life Sciences
WVE
+$3.52M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COGT icon
1
Cogent Biosciences
COGT
$5.94B
$45.1M 12.79%
1,170,740
SNDX icon
2
Syndax Pharmaceuticals
SNDX
$1.75B
$43.3M 12.3%
1,855,000
CLDX icon
3
Celldex Therapeutics
CLDX
$2.49B
$27.4M 7.79%
865,000
CTMX icon
4
CytomX Therapeutics
CTMX
$790M
$21.4M 6.07%
4,550,000
+3,850,000
KALV icon
5
KalVista Pharmaceuticals
KALV
$1.43B
$20.6M 5.84%
1,021,300
+220,000
CGON icon
6
CG Oncology
CGON
$5.44B
$19.7M 5.61%
291,800
-200,700
VERA icon
7
Vera Therapeutics
VERA
$2.56B
$19.4M 5.51%
482,500
PCVX icon
8
Vaxcyte
PCVX
$7.38B
$18.4M 5.22%
316,500
+25,000
PHVS icon
9
Pharvaris
PHVS
$2.1B
$13.4M 3.82%
475,750
TYRA icon
10
Tyra Biosciences
TYRA
$2.01B
$13.4M 3.81%
350,000
BEAM icon
11
Beam Therapeutics
BEAM
$3.45B
$11.4M 3.22%
476,338
VRDN icon
12
Viridian Therapeutics
VRDN
$1.94B
$10.5M 2.97%
534,931
-323,700
BCRX icon
13
BioCryst Pharmaceuticals
BCRX
$2.25B
$9.52M 2.7%
1,000,000
-1,150,000
UTHR icon
14
United Therapeutics
UTHR
$23.4B
$8.89M 2.53%
15,000
+4,000
CGEM icon
15
Cullinan Oncology
CGEM
$1.03B
$7.53M 2.14%
530,000
+220,000
NRIX icon
16
Nurix Therapeutics
NRIX
$1.83B
$7.13M 2.02%
460,000
MBX
17
MBX Biosciences
MBX
$1.5B
$6.3M 1.79%
211,000
KRYS icon
18
Krystal Biotech
KRYS
$9.11B
$5.68M 1.61%
22,000
DBVT
19
DBV Technologies
DBVT
$1.13B
$5.54M 1.57%
+265,000
RLAY icon
20
Relay Therapeutics
RLAY
$3.08B
$5.34M 1.52%
536,946
TVTX icon
21
Travere Therapeutics
TVTX
$4.38B
$5.28M 1.5%
177,600
+67,600
PTGX icon
22
Protagonist Therapeutics
PTGX
$6.39B
$4.01M 1.14%
38,000
URGN icon
23
UroGen Pharma
URGN
$1.37B
$3.96M 1.12%
220,000
+120,000
ALMS
24
Alumis Inc
ALMS
$2.75B
$2.86M 0.81%
+130,000
BMRN icon
25
BioMarin Pharmaceuticals
BMRN
$10.9B
$2.66M 0.75%
47,000
-35,000
1
2